Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics
July 27 2016 - 1:25PM
Dow Jones News
By Peg Brickley
Pfizer Inc. won bankruptcy-court approval Wednesday to buy the
assets of Bind Therapeutics after an auction doubled Pfizer's
starting offer, for a final price of $40 million.
The results mean estimated profits of $22.5 million to be
divided among Bind shareholders, company lawyer Peter Gilhuly said
at the Wednesday court hearing when the sale was approved.
"To call this a success would be an understatement," said Judge
Brendan Shannon of the U.S. Bankruptcy Court in Wilmington,
Del.
When Bind filed for chapter 11 protection on May 1, it had
limited funds and time to find a buyer for its business. The sale
price means the business, which develops drug treatments that use
nanoparticles to treat cancer, will continue in Pfizer's hands. The
deal also enables Bind to pay its bills and will allow shareholders
to walk away with some cash.
"We will pay every creditor in full, and we will have a
substantial distribution," Mr. Gilhuly said.
Bind's shareholders include Koch Industries Inc.'s David Koch,
Polaris Partners, and company co-founder Robert S. Langer Jr., who
is a David H. Koch Institute professor at the Massachusetts
Institute of Technology.
Pfizer was up against international competition at the
bankruptcy auction, which stretched over a period of days.
Japan's NanoCarrier Co. Ltd. stepped up first, topping Pfizer's
opening offer. Like Bind, NanoCarrier grew out of university
research in the use of nanoparticle technology to treat cancer,
according to its website. NanoCarrier was designated the backup
bidder for Bind, and will complete a deal if Pfizer fails to
close.
Pfizer expects to close the transaction Monday, said Thomas
Califano, a lawyer for Pfizer.
Germany's MagForce AG also entered the competition for Bind's
operation, Mr. Gilhuly said. MagForce claims bragging rights as the
"first and only nanotechnology-based therapy" with European
regulatory approval for the treatment of brain tumors.
Based in Cambridge, Mass., Bind was founded in 2007 by
Massachusetts Institute of Technology and Harvard Medical School
professors. It filed for bankruptcy protection after the company
received a notice of default from lender Hercules Technology III LP
demanding immediate payment of $14.5 million on a loan.
--Patrick Fitzgerald and Jacqueline Palank contributed to this
article.
Write to Peg Brickley at peg.brickley@wsj.com
(END) Dow Jones Newswires
July 27, 2016 13:10 ET (17:10 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024